Browsing "1. Journal Papers" by Author : 1549

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 301 to 360 of 463

This table browses all dspace content
Issue DateTitleJournal Title
2012Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.LIVER INTERNATIONAL
2021Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization CURRENT ONCOLOGY
2019Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis JOURNAL OF CLINICAL MEDICINE
2018Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillanceALIMENTARY PHARMACOLOGY & THERAPEUTICS
2013Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation YONSEI MEDICAL JOURNAL
2022Predictors of Sarcopenia in an Obese Asian PopulationNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2008Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study.LIVER INTERNATIONAL
2017Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver DiseaseDIGESTIVE DISEASES AND SCIENCES
2022Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis BDIGESTIVE DISEASES AND SCIENCES
2020Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases INTESTINAL RESEARCH
2020Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation CANCERS
2014Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesionsCLINICAL & EXPERIMENTAL METASTASIS
2019Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by AntiviralsCLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2011Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomyJOURNAL OF GASTROINTESTINAL SURGERY
2017Prognostic factors of sorafenib therapy in hepatocellular carcinoma patients with failure of transarterial chemoembolizationHEPATOLOGY INTERNATIONAL
2014Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis YONSEI MEDICAL JOURNAL
2015Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolizationLIVER INTERNATIONAL
2016Prognostic Significance of ¹?F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study JOURNAL OF NUCLEAR MEDICINE
2011Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenibLIVER INTERNATIONAL
2021Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma YONSEI MEDICAL JOURNAL
2017Prognostic Value of FDG Uptake of Portal Vein Tumor Thrombosis in Patients With Locally Advanced Hepatocellular CarcinomaCLINICAL NUCLEAR MEDICINE
2013Prognostic Value of Model for End-Stage Liver Disease Scores in Patients with Fulminant Hepatic FailureTRANSPLANTATION PROCEEDINGS
2011Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.EUROPEAN JOURNAL OF CANCER
2015Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis BLIVER INTERNATIONAL
2013Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization BMC CANCER
2019Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive InfectionCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2012Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B PLOS ONE
2012Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B PLOS ONE
2010Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosisLIVER INTERNATIONAL
2013Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma CANCER RESEARCH
2011Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.HEPATOLOGY
2013Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B GUT AND LIVER
2016Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis PLOS ONE
2015Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective StudyAMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
2012Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinomaALIMENTARY PHARMACOLOGY & THERAPEUTICS
2019Radiomics on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma CLINICAL CANCER RESEARCH
2018Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosisCANCER CHEMOTHERAPY AND PHARMACOLOGY
2016Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data CANCER RESEARCH AND TREATMENT
2016Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis BLIVER INTERNATIONAL
2019Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection PLOS ONE
2015Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography PLOS ONE
2018Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion"AMERICAN JOURNAL OF ROENTGENOLOGY
2018Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenibLIVER INTERNATIONAL
2009Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavirANTIVIRAL THERAPY
2019Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinomaRADIOTHERAPY AND ONCOLOGY
2020Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imagingHEPATOLOGY INTERNATIONAL
2021Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients JOURNAL OF KOREAN MEDICAL SCIENCE
2021Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY
2014Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.HEPATOLOGY
2012Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement.DIGESTION
2011Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.AMERICAN JOURNAL OF GASTROENTEROLOGY
2011Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).HEPATOLOGY
2021Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2019Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B CLINICAL AND MOLECULAR HEPATOLOGY
2014Risk Assessment of Liver-related Events Using Transient Elastography in Patients With Chronic Hepatitis B Receiving EntecavirJOURNAL OF CLINICAL GASTROENTEROLOGY
2011Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.LANCET ONCOLOGY
2016Risk prediction for patients with hepatocellular carcinoma undergoing chemoembolization: development of a prediction modelLIVER INTERNATIONAL
2021Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2009Role of serum prothrombin induced by vitamin K absence or antagonist-II in the early detection of hepatocellular carcinoma in patients with chronic hepatitis B virus infectionSCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
1 5 678

Browse

Links